NCT01519128View on ClinicalTrials.gov

A Study to Investigate the Effect of Steady-State TMC278 on the Pharmacokinetics of a Single Dose of Digoxin

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Healthy
Interventions
DRUG

Treatment A: Digoxin

Type=exact number, unit=mg, number=0.5, form=tablet, route=oral. Digoxin administered on Day 1.

DRUG

Treatment B: TMC278

Type=exact number, unit=mg, number=25, form=tablet, route=oral. TMC278 administered for 16 days, with digoxin administered in the morning on Day 11.

Trial Locations (1)

Unknown

Merksem

All Listed Sponsors
lead

Janssen R&D Ireland

INDUSTRY

NCT01519128 - A Study to Investigate the Effect of Steady-State TMC278 on the Pharmacokinetics of a Single Dose of Digoxin | Biotech Hunter | Biotech Hunter